Home
News
Create
Screeners
Insights
Ganga Pharmaceuticals
12.
00
-12.00
(-100.00%)
Market Cap
₹7.10 Cr
PE Ratio
488.20
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-100.00%
1M
0.00%
6M
-100.00%
1Y
-100.00%
5Y
-100.00%
View Company Insights
Latest news about Ganga Pharmaceuticals
Ganga Pharmaceuticals Opens Special Window for Physical Share Transfer and Dematerialisation
Mar 16, 2026
Ganga Pharmaceuticals Limited has opened a special one-year window from February 05, 2026 to February 04, 2027 for transfer and dematerialisation of physical securities following SEBI circular guidelines. The facility addresses shares sold/purchased before April 01, 2019, or previously rejected due to documentation issues. KFin Technologies Limited will process requests, with transferred shares credited only in demat mode and subject to a one-year lock-in period.
Ganga Pharmaceuticals Limited Re-appoints Managing Director for Three-Year Term
Mar 10, 2026
Ganga Pharmaceuticals Reports Decline in Revenue and Profit for H1 FY2026
Nov 07, 2025
Plutus Capital Management Acquires 7.75% Stake in Ganga Pharmaceuticals Through Warrant Conversion
Sep 19, 2025
Plutus Capital Management Acquires 7.75% Stake in Ganga Pharmaceuticals Through Warrant Conversion
Aug 05, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO